Advertisement

Science China Life Sciences

, Volume 60, Issue 11, pp 1271–1275 | Cite as

Trend analysis of cancer incidence and mortality in China

  • Fang Wei
  • Yingfen Wu
  • Le Tang
  • Fang Xiong
  • Can Guo
  • Xiayu Li
  • Ming Zhou
  • Bo Xiang
  • Xiaoling Li
  • Guiyuan Li
  • Wei Xiong
  • Zhaoyang Zeng
Insight

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Notes

Acknowledgements

This work was supported by the National Natural Science Foundation of China (81372907, 81472531, 81472595, 81672683, 81672688, 81772928), the Natural Science Foundation of Hunan Province (2015JJ1022, 2016JC2035) and the Fundamental Research Funds of the Central South University (2014zzts066).

References

  1. Campisi, J. (2005). Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell 120, 513–522.CrossRefPubMedGoogle Scholar
  2. Cao, Y., DePinho, R.A., Ernst, M., and Vousden, K. (2011). Cancer research: past, present and future. Nat Rev Cancer 11, 749–754.CrossRefPubMedGoogle Scholar
  3. Chen, W., Zheng, R., Baade, P.D., Zhang, S., Zeng, H., Bray, F., Jemal, A., Yu, X.Q., and He, J. (2016a). Cancer statistics in China, 2015. CA Cancer J Clin 66, 115–132.CrossRefPubMedGoogle Scholar
  4. Chen, W., Zheng, R., Zeng, H., and Zhang, S. (2014a). Trend analysis of the changes of male/female, urban/rural incidences and average age of cancer patients in China 1989–2008. Zhonghua Zhong Liu Za Zhi 36, 796–800.PubMedGoogle Scholar
  5. Chen, S., Zhu, J.H., Wang, F., Huang, S.Y., Xue, W.Q., Cui, Z., He, J., and Jia, W.H. (2015). Association of the Asp312Asn and Lys751Gln polymorphisms in the XPD gene with the risk of non-Hodgkin’s lymphoma: evidence from a meta-analysis. Chin J Cancer 34, 2–12.CrossRefPubMedCentralGoogle Scholar
  6. Chen, W., Zheng, R., Zhang, S., Zeng, H., Xia, C., Zuo, T., Yang, Z., Zou, X., and He, J. (2017a). Cancer incidence and mortality in China, 2013. Cancer Lett 401, 63–71.CrossRefPubMedGoogle Scholar
  7. Chen, W., Zheng, R., Zhang, S., Zeng, H., Zuo, T., Xia, C., Yang, Z., and He, J. (2017b). Cancer incidence and mortality in China in 2013: an analysis based on urbanization level. Chin J Cancer Res 29, 1–10.CrossRefPubMedPubMedCentralGoogle Scholar
  8. Chen, W., Zheng, R., Zhang, S., Zhao, P., Li, G., Wu, L., and He, J. (2013). Report of incidence and mortality in China cancer registries, 2009. Chin J Cancer Res 25, 10–21.PubMedPubMedCentralGoogle Scholar
  9. Chen, W., Zheng, R., Zhang, S., Zhao, P., Zeng, H., Zou, X., and He, J. (2014b). Annual report on status of cancer in China, 2010. Chin J Cancer Res 26, 48–58.PubMedPubMedCentralGoogle Scholar
  10. Chen, X., Ye, G., Zhang, C., Li, X., and Shen, K. (2016b). Non-anthracycline-containing docetaxel and cyclophosphamide regimen is associated with sustained worse outcome compared with docetaxel, anthracycline and cyclophosphamide in neoadjuvant treatment of triple negative and HER2-positive breast cancer patients: updated follow-up data from NATT study. Chin J Cancer Res 28, 561–569.CrossRefPubMedPubMedCentralGoogle Scholar
  11. Dawson, M.A., and Kouzarides, T. (2012). Cancer epigenetics: from mechanism to therapy. Cell 150, 12–27.CrossRefPubMedGoogle Scholar
  12. Di, S., and Li, Z. (2016). Treatment of solid tumors with chimeric antigen receptor-engineered T cells: current status and future prospects. Sci China Life Sci 59, 360–369.CrossRefPubMedGoogle Scholar
  13. Friedl, P., and Alexander, S. (2011). Cancer invasion and the microenvironment: plasticity and reciprocity. Cell 147, 992–1009.CrossRefPubMedGoogle Scholar
  14. Hanahan, D., and Weinberg, R.A. (2011). Hallmarks of cancer: the next generation. Cell 144, 646–674.CrossRefPubMedGoogle Scholar
  15. Hu, S.Y., Zheng, R., Zhao, F., Zhang, S., Chen, W., and Qiao, Y. (2014). Trend analysis of cervical cancer incidence and mortality rates in Chinese women during 1989–2008. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 36, 119–125.PubMedGoogle Scholar
  16. Ke, T., Fang, W., Hao, B., HongBin, H., WenLing, Z., ZhaoJian, G., Yu, L.X., YaLi, S., and QianJin, L. (2014). Cloning and functional characterization of a novel long non-coding RNA gene associated with hepatocellular carcinoma. Prog Biochem Biophys 41, 153–162.Google Scholar
  17. Li, G., and Chen, W. (2009). Representativeness of population-based cancer registration in China—comparison of urban and rural areas. Asian Pac J Cancer Prev 10, 559–564.PubMedGoogle Scholar
  18. Liao, Q., Zeng, Z., Guo, X., Li, X., Wei, F., Zhang, W., Li, X., Chen, P., Liang, F., Xiang, B., Ma, J., Wu, M., Tang, H., Deng, M., Zeng, X., Tang, K., Xiong, W., and Li, G. (2013). LPLUNC1 suppresses IL-6-induced nasopharyngeal carcinoma cell proliferation via inhibiting the Stat3 activation. Oncogene 33, 2098–2109.CrossRefPubMedGoogle Scholar
  19. Luo, J., Solimini, N.L., and Elledge, S.J. (2009). Principles of cancer therapy: oncogene and non-oncogene addiction. Cell 136, 823–837.CrossRefPubMedPubMedCentralGoogle Scholar
  20. Morris, L.G.T., Sikora, A.G., Tosteson, T.D., and Davies, L. (2013). The increasing incidence of thyroid cancer: the influence of access to care. Thyroid 23, 885–891.CrossRefPubMedPubMedCentralGoogle Scholar
  21. Siegel, R.L., Miller, K.D., and Jemal, A. (2016). Cancer statistics, 2016. CA Cancer J Clin 66, 7–30.CrossRefPubMedGoogle Scholar
  22. Siegel, R.L., Miller, K.D., and Jemal, A. (2017). Cancer statistics, 2017. CA Cancer J Clin 67, 7–30.CrossRefPubMedGoogle Scholar
  23. Stewart, B., and Wild, C. (2014). World cancer report. Lyon: International Agency for Research on Cancer.Google Scholar
  24. Tang, L.L., Chen, W.Q., Xue, W.Q., He, Y.Q., Zheng, R.S., Zeng, Y.X., and Jia, W.H. (2016). Global trends in incidence and mortality of nasopharyngeal carcinoma. Cancer Lett 374, 22–30.CrossRefPubMedGoogle Scholar
  25. Torre, L.A., Bray, F., Siegel, R.L., Ferlay, J., Lortet-Tieulent, J., and Jemal, A. (2015). Global cancer statistics, 2012. CA Cancer J Clin 65, 87–108.CrossRefPubMedGoogle Scholar
  26. Varghese, C., and Shin, H.R. (2014). Strengthening cancer control in China. Lancet Oncol 15, 484–485.CrossRefPubMedGoogle Scholar
  27. Wang, J.B., Jiang, Y., Liang, H., Li, P., Xiao, H.J., Ji, J., Xiang, W., Shi, J.F., Fan, Y.G., Li, L., Wang, D., Deng, S.S., Chen, W.Q., Wei, W.Q., Qiao, Y.L., and Boffetta, P. (2012). Attributable causes of cancer in China. Ann Oncol 23, 2983–2989.CrossRefPubMedGoogle Scholar
  28. Wang, Y., Chen, T., Lu, L.L., Wang, M., Wang, D., Yao, H., Fan, C., Qi, J., Zhang, Y., and Qu, C. (2017a). Adolescent booster with hepatitis B virus vaccines decreases HBV infection in high-risk adults. Vaccine 35, 1064–1070.CrossRefPubMedGoogle Scholar
  29. Wang, Y., Mo, Y., Gong, Z., Yang, X., Yang, M., Zhang, S., Xiong, F., Xiang, B., Zhou, M., Liao, Q., Zhang, W., Li, X., Li, X., Li, Y., Li, G., Zeng, Z., and Xiong, W. (2017b). Circular RNAs in human cancer. Mol Cancer 16, 25.CrossRefPubMedPubMedCentralGoogle Scholar
  30. Wen, C.J., and Chen, S.J. (2016). National research center for translational medicine · Shanghai—national key scientific infrastructure for translational medicine. Sci China Life Sci 59, 1051–1054.CrossRefPubMedGoogle Scholar
  31. Yang, Y., Liao, Q., Wei, F., Li, X., Zhang, W., Fan, S., Shi, L., Li, X., Gong, Z., Ma, J., Zhou, M., Xiang, J., Peng, S., Xiang, B., Deng, H., Yang, Y., Li, Y., Xiong, W., Zeng, Z., and Li, G. (2013). LPLUNC1 inhibits nasopharyngeal carcinoma cell growth via down-regulation of the MAP kinase and cyclin D1/E2F pathways. PLoS ONE 8, e62869.CrossRefPubMedPubMedCentralGoogle Scholar
  32. Zeng, H., Zheng, R., Guo, Y., Zhang, S., Zou, X., Wang, N., Zhang, L., Tang, J., Chen, J., Wei, K., Huang, S., Wang, J., Yu, L., Zhao, D., Song, G., Chen, J., Shen, Y., Yang, X., Gu, X., Jin, F., Li, Q., Li, Y., Ge, H., Zhu, F., Dong, J., Guo, G., Wu, M., Du, L., Sun, X., He, Y., Coleman, M.P., Baade, P., Chen, W., and Yu, X.Q. (2015). Cancer survival in China, 2003–2005: a population-based study. Int J Cancer 136, 1921–1930.CrossRefPubMedGoogle Scholar
  33. Zeng, H., Zheng, R., Zhang, S., Zhao, P., He, J., and Chen, W. (2012). Trend analysis of cancer mortality in China between 1989 and 2008. Zhonghua Zhong Liu Za Zhi 34, 525–531.PubMedGoogle Scholar
  34. Zeng, Z.Y., Huang, H.B., Huang, L.L., Sun, M.X., Yan, Q.J., Song, Y.L., Wei, F., Bo, H., Gong, Z.J., Zeng, Y., Li, Q., Zhang, W.L., Li, X.Y., Xiang, B., Li, X.L., Li, Y., Xiong, W., and Li, G.Y. (2014). Regulation network and expression profiles of Epstein-Barr virus-encoded microRNAs and their potential target host genes in nasopharyngeal carcinomas. Sci China Life Sci 57, 315–326.CrossRefPubMedGoogle Scholar
  35. Zeng, Z.Y., Huang, H.B., Zhang, W.L., Xiang, B., Zhou, M., Zhou, Y.H., Ma, J., Yi, M., Li, X.Y., Li, X.L., Xiong, W., and Li, G.Y. (2011). Nasopharyngeal carcinoma: advances in genomics and molecular genetics. Sci China Life Sci 54, 966–975.CrossRefPubMedGoogle Scholar
  36. Zhao, P., Dai, M., Chen, W., and Li, N. (2010). Cancer trends in China. Jpn J Clin Oncol 40, 281–285.CrossRefPubMedGoogle Scholar
  37. Zheng, R., Peng, X., Zeng, H., Zhang, S., Chen, T., Wang, H., and Chen, W. (2015). Incidence, mortality and survival of childhood cancer in China during 2000–2010 period: a population-based study. Cancer Lett 363, 176–180.CrossRefPubMedGoogle Scholar
  38. Zheng, R., Zeng, H., Zhang, S., Chen, T., and Chen, W. (2016). National estimates of cancer prevalence in China, 2011. Cancer Lett 370, 33–38.CrossRefPubMedGoogle Scholar

Copyright information

© Science China Press and Springer-Verlag GmbH Germany, part of Springer Nature 2017

Authors and Affiliations

  • Fang Wei
    • 1
    • 2
    • 3
  • Yingfen Wu
    • 2
  • Le Tang
    • 2
  • Fang Xiong
    • 1
  • Can Guo
    • 2
  • Xiayu Li
    • 2
    • 3
  • Ming Zhou
    • 1
    • 2
    • 3
  • Bo Xiang
    • 1
    • 2
    • 3
  • Xiaoling Li
    • 1
    • 2
    • 3
  • Guiyuan Li
    • 1
    • 2
    • 3
  • Wei Xiong
    • 1
    • 2
    • 3
  • Zhaoyang Zeng
    • 1
    • 2
    • 3
  1. 1.Key Laboratory of Carcinogenesis of Ministry of Health, Xiangya HospitalCentral South UniversityChangshaChina
  2. 2.Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Cancer Research InstituteCentral South UniversityChangshaChina
  3. 3.Hunan Key Laboratory of Nonresolving Inflammation and Cancer, Disease Genome Research Center, the Third Xiangya HospitalCentral South UniversityChangshaChina

Personalised recommendations